How Collaboration Builds Better Treatments for Chronic Lymphocytic Leukemia

Seema Bhat, MD

May 30, 2023

Seema Bhat, MD, poses the past era of chemoimmunotherapy against the new age of Bruton tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia.

Noting the often deleterious side effects of chemotherapy, Dr Bhat characterizes recent therapeutic advances as the reward of collaboration between researchers and clinicians striving to develop forms of treatment that provide lasting effects with fewer costs.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: How Collaboration Builds Better Treatments for Chronic Lymphocytic Leukemia - Medscape - May 30, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.